ArticleArchives of dermatological research2025
Treatment of acne scars using subcision combined with concentrated growth factors versus subcision monotherapy: a retrospective cohort study.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Subcision is one of the most frequently used surgical options in improving acne scarring. Concentrated growth factors (CGF), with the potential to assist in the repair and regeneration of tissues, have been extended to the field of cosmetic plastic surgery. Here, we investigate the safety and efficacy of combining CGF (the latest generation of platelet concentrates) with subcision as a novel treatment method. Sixty patients with clinically diagnosed acne scars received either subcision combined with CGF (n = 24) or subcision monotherapy (n = 36). Clinical characteristics and treatment outcomes were documented through photographs, questionnaires, and medical records, with side effects recorded. Both groups showed significant scar improvements, but the combination therapy demonstrated superior outcomes in ECCA score reduction compared to subcision treatment alone. Patients in the combination therapy group reported higher satisfaction levels, and side effects were minimal, except for increased ecchymosis and pain levels which resolved within an acceptable recovery time range for the patients. This combination approach efficiently treats severe acne scars without significant safety risks.
Indexed as
Identifiers
39994089What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.